Try our Advanced Search for more refined results
Health - February, 2005
26 articles
- Supreme Court Requests Solicitor General's Views In LabCorp. Patent Suit
- Geron Wins Patent Interference Vs. ACT Over Cloning Technology
- Teva Challenges Shire's Adderall XR Patent
- Court Extends Pre-Trial Order Deadline In Plavix Patent Suit
- Dorsey & Whitney Life-Sciences Co-Chair Jumps Ship To Dechert
- Pharma Litigator Leaves Fitzpatrick Cella, Joins Sidley
- Novartis To Topple Teva As World's Largest Generics Maker
- Pfizer Sues Ranbaxy, Teva Over Accupril Patent
- Glaxo Sues Spectrum Pharma Over Imitrex Patent Challenge
- Medtronic Infringes Guidant Stent Patents, Jury Finds
- Canada Mulls Ban On Exports Of Patented Drugs
- Conor Countersues Angiotech, Boston Scientific
- U.S. Agency Seeks Reexamination Of Biotech Patent
- Teva, Glaxo Settle Suit Over Generic Lamictal
- India To Unveil Guidelines For Biotech Patents
- Arbitrator Rules For University Of California In Royalty Case Over Laser Technology
- Judge Rules For Yale In Patent Dispute With Former Professor
- In Curious Test Case, USPTO Rejects Patent On Human Life Form
- Pfizer, Microsoft Team Up In Legal Onslaught Against "Viagra" Purveyors
- European Patent Office Affirms Revocation Of Viagra Patent
- Barr Wins Patent Challenge Vs. Ferring, Aventis
- Barr Sues FDA Over Exclusivity for Generic Allegra-D
- Glaxo Agrees To $65M Settlement In Antitrust Suit Over Paxil Patent Gaming: Report
- California Supreme Court To Review $500M Judgment Vs. Genentech
- Angiotech, Boston Scientific Sue Conor Medsystems Over Drug-Coated Stents
- European Patent Office Revokes Applera Online-PCR Patent